Annual Drug Patent Expirations for ACZONE
Aczone is a drug marketed by Allergan and Almirall and is included in two NDAs. It is available from four suppliers. There are two patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for ACZONE.
This drug has twenty-one patent family members in fifteen countries.
The generic ingredient in ACZONE is dapsone. Four suppliers are listed for this compound. Additional details are available on the dapsone profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com